Patents by Inventor Shyam KRISHNAN
Shyam KRISHNAN has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 11871050Abstract: Some implementations include methods for replacing advertisements that have been inserted into a manifest associated with live streaming and may include receiving a request for a manifest from a player to enable a user to watch a live stream of an event. The request may be received at a first time when the live stream is already in progress. The manifest may be generated to include content fragments associated with the live event and advertisements based on first set of selection criteria. The manifest may be sent to the player to enable the user to watch the live stream. A seek back request may be received from the player to enable the user to watch the live stream at a second time earlier than the first time. The manifest may be updated to replace at least one advertisement with a replacement advertisement selected based on second set of selection criteria.Type: GrantFiled: August 17, 2021Date of Patent: January 9, 2024Assignee: Amazon Technologies, Inc.Inventors: Kyle Koceski, Shyam Krishnan Moni, Varun Chadha, Yongjun Wu, Abhishek Kumar
-
Publication number: 20230357347Abstract: This disclosure features chemical entities (e.g., a compound or a pharmaceutically acceptable salt and/or hydrate and/or prodrug of the compound) that modulate (e.g., agonize or partially agonize or antagonize) glucagon-like peptide-1 receptor (“GLP-1R”) and/or the gastric inhibitory polypeptide receptor (“GIPR”). The chemical entities are useful, e.g., for treating a subject (e.g., a human) having a disease, disorder, or condition in which modulation (e.g., agonism, partial agonism or antagonism) of GLP-1R and/or GIPR activities is beneficial for the treatment or prevention of the underlying pathology and/or symptoms and/or progression of the disease, disorder, or condition. In some embodiments, the modulation results in an enhancement of (e.g., an increase in) existing levels (e.g., normal or below normal levels) of GLP-1R and/or GIPR activity (e.g., signaling). In some embodiments, the chemical entities described herein further modulate (e.g.Type: ApplicationFiled: December 22, 2022Publication date: November 9, 2023Inventors: Johan Enquist, Shyam Krishnan, Suman Atwal, Daniel Erlanson, Raymond V. Fucini, Stig Hansen, Andrew Sawayama, Steven Sethofer
-
Publication number: 20230187808Abstract: An exemplary embodiment of the present disclosure provides a wireless network system comprising a mobile access point, a wireless device, and an actuator. The actuator further configured to move the mobile access point to a position having an improved line of sight condition between the wireless device and the mobile access point.Type: ApplicationFiled: May 11, 2021Publication date: June 15, 2023Inventors: Yubing Jian, Raghupathy Sivakumar, Shyam Krishnan Venkateswaran, Ching-Lun Tai
-
Publication number: 20230151074Abstract: This disclosure features chemical entities (e.g., a compound or a pharmaceutically acceptable salt) that modulate (e.g., agonize or partially agonize or antagonize) glucagon-like peptide-1 receptor (“GLP-1R”) and/or the gastric inhibitory polypeptide receptor (“GIPR”). The chemical entities are useful, e.g., for treating a disease, disorder, or condition in which modulation (e.g., agonism, partial agonism or antagonism) of GLP-1R and/or GIPR activities is beneficial for the treatment or prevention of the underlying pathology and/or symptoms and/or progression of the disease, disorder, or condition. In some embodiments, modulation results in enhancement of (e.g., increases) existing levels (e.g., normal or below normal levels) of GLP-1R and/or GIPR activity (e.g., signaling). In some embodiments, the chemical entities described herein further modulate (e.g., attenuate, uncouple) ?-arrestin signaling relative to what is observed with the native ligand.Type: ApplicationFiled: May 13, 2022Publication date: May 18, 2023Inventors: Daniel Erlanson, Raymond V. Fucini, Stig Hansen, Jeff Iwig, Shyam Krishnan, Enrique Moya, Steven Sethofer
-
Patent number: 11535660Abstract: This disclosure features chemical entities (e.g., a compound or a pharmaceutically acceptable salt and/or hydrate and/or prodrug of the compound) that modulate (e.g., agonize or partially agonize or antagonize) glucagon?like peptide?1 receptor (“GLP?1R”) and/or the gastric inhibitory polypeptide receptor (“GIPR”). The chemical entities are useful, e.g., for treating a subject (e.g., a human) having a disease, disorder, or condition in which modulation (e.g., agonism, partial agonism or antagonism) of GLP?1R and/or GIPR activities is beneficial for the treatment or prevention of the underlying pathology and/or symptoms and/or progression of the disease, disorder, or condition. In some embodiments, the modulation results in an enhancement of (e.g., an increase in) existing levels (e.g., normal or below normal levels) of GLP?1R and/or GIPR activity (e.g., signaling). In some embodiments, the chemical entities described herein further modulate (e.g.Type: GrantFiled: March 22, 2019Date of Patent: December 27, 2022Assignee: Cannot Therapeutics, Inc.Inventors: Johan Enquist, Shyam Krishnan, Suman Atwal, Daniel Erlanson, Raymond V. Fucini, Stig Hansen, Andrew Sawayama, Steven Sethofer
-
Patent number: 11442717Abstract: A network device includes a first agent programmed to provide a functionality of the network device. The network device also includes a message bus, distinct from the first agent, that identifies an update associated with the first agent, the update includes differential state information based, at least in part, on a state of the first agent, the state of the first agent is stored in a data structure exclusively managed by the first agent; in response to identifying the update: identifies a second agent that is subscribed to the first agent; and performs an action set to provide the second agent with access to the update.Type: GrantFiled: March 31, 2020Date of Patent: September 13, 2022Assignee: Arista Networks, Inc.Inventors: Roman Olegovich Chertov, Adam James Sweeney, Hugh W. Holbrook, Karthik Shyam Krishnan Subraveti
-
Patent number: 11356516Abstract: Methods and apparatus are described for facilitating the client-side caching of media content based on one or more properties of the media content. Information relating to the cacheability of different types of content is communicated to the media player on a client device in the manifest or playlist employed by the media player to request fragments of the media content. The media player uses this information to make decisions about how to cache the corresponding content.Type: GrantFiled: July 23, 2021Date of Patent: June 7, 2022Assignee: Amazon Technologies, Inc.Inventors: Yongjun Wu, Kyle Koceski, Kyle Alexander Woo, Vasanthakumar Soundararajan, Shiranchai Taneja, Shyam Krishnan Krishnan Moni, Jake O'Halloran
-
Publication number: 20210303288Abstract: A network device includes a first agent programmed to provide a functionality of the network device. The network device also includes a message bus, distinct from the first agent, that identifies an update associated with the first agent, the update includes differential state information based, at least in part, on a state of the first agent, the state of the first agent is stored in a data structure exclusively managed by the first agent; in response to identifying the update: identifies a second agent that is subscribed to the first agent; and performs an action set to provide the second agent with access to the update.Type: ApplicationFiled: March 31, 2020Publication date: September 30, 2021Inventors: Roman Olegovich Chertov, Adam James Sweeney, Hugh W. Holbrook, Karthik Shyam Krishnan Subraveti
-
Patent number: 11070418Abstract: A network device includes a storage and a message bus. The storage stores subscription information. The message bus distributes state information associated with a first agent to at least two agents based on the subscription information. The message bus is distinct from the first agent. The state information is stored in a data structure exclusively managed by the first agent. The message bus, after distributing the state information, makes a determination that a connection to one of the at least two agents has been closed; and performs, based on the determination, an action set to prevent attempts to distribute future state information to the one of the at least two agents.Type: GrantFiled: March 31, 2020Date of Patent: July 20, 2021Assignee: Arista Networks, Inc.Inventors: Roman Olegovich Chertov, Adam James Sweeney, Hugh W. Holbrook, Karthik Shyam Krishnan Subraveti
-
Patent number: 9580427Abstract: Provided herein are compounds such as the compounds having the structure of Formula (XI) and methods of using the same, such as methods of inhibiting kinases.Type: GrantFiled: May 16, 2012Date of Patent: February 28, 2017Assignee: The Regents of the University of CaliforniaInventors: John William Taunton, Jr., Jesse McFarland, Shyam Krishnan, Jonathan Choy
-
Patent number: 9505766Abstract: Methods of inhibiting kinases using kinase inhibitors having olefin moieties are disclosed.Type: GrantFiled: August 18, 2014Date of Patent: November 29, 2016Assignee: THE REGENTS OF THE UNIVERSITY OF CALIFORNIAInventors: John William Taunton, Jr., Rebecca Maglathlin, Iana Serafimova, Michael S. Cohen, Rand Miller, Ville Paavilainen, Jesse McFarland, Shyam Krishnan
-
Patent number: 9452974Abstract: Provided herein are compositions including diastereomers in substantially diastereomerically pure form and enantiomers in substantially enantiomerically pure form, and processes for preparing them and converting them to metyrosine.Type: GrantFiled: August 8, 2014Date of Patent: September 27, 2016Assignee: ATON PHARMA, INC.Inventors: Kevin John Halloran, Alex Comely, Zhengming Chen, Shyam Krishnan
-
Publication number: 20150045343Abstract: Methods of inhibiting kinases using kinase inhibitors having olefin moieties are disclosed.Type: ApplicationFiled: August 18, 2014Publication date: February 12, 2015Inventors: John William Taunton, Jr., Rebecca Maglathlin, Iana Serafimova, Michael S. Cohen, Rand Miller, Ville Paavilainen, Jesse McFarland, Shyam Krishnan
-
Publication number: 20140350284Abstract: Provided herein are compositions including diastereomers in substantially diastereomerically pure form and enantiomers in substantially enantiomerically pure form, and processes for preparing them and converting them to metyrosine.Type: ApplicationFiled: August 8, 2014Publication date: November 27, 2014Inventors: Kevin John HALLORAN, Alex COMELY, Zhengming CHEN, Shyam KRISHNAN
-
Publication number: 20140323464Abstract: Provided herein are kinase inhibiting compounds and methods of using the same.Type: ApplicationFiled: May 16, 2012Publication date: October 30, 2014Inventors: John William Taunton, JR., Kenneth Albert Brameld, David Michael Goldstein, Jesse Mcfarland, Shyam Krishnan, Jonathan Choy
-
Patent number: 8841486Abstract: Provided herein are compositions including diastereomers in substantially diastereomerically pure form and enantiomers in substantially enantiomerically pure form, and processes for preparing them and converting them to metyrosine.Type: GrantFiled: October 29, 2010Date of Patent: September 23, 2014Assignee: Aton PharmaInventors: Kevin John Halloran, Alex Comely, Zhengming Chen, Shyam Krishnan
-
Publication number: 20130035325Abstract: Methods of inhibiting kinases using kinase inhibitors having olefin moieties are disclosed.Type: ApplicationFiled: November 16, 2010Publication date: February 7, 2013Applicant: THE REGENTS OF THE UNIVERSITY OF CALIFORNIAInventors: John William Taunton, JR., Rebecca Maglathlin, Iana Serafimova, Michael S. Cohen, Rand Miller, Ville Paavilainen, Jesse McFarland, Shyam Krishnan
-
Publication number: 20110104765Abstract: Provided herein are compositions including diastereomers in substantially diastereomerically pure form and enantiomers in substantially enantiomerically pure form, and processes for preparing them and converting them to metyrosine.Type: ApplicationFiled: October 29, 2010Publication date: May 5, 2011Inventors: Kevin John HALLORAN, Alex COMELY, Zhengming CHEN, Shyam KRISHNAN
-
Patent number: 7773003Abstract: A method for decoding an input bit stream encoded using Huffman encoding generates a lookup table using a standard Huffman code book. Thereafter, at least three bits are extracted from the input bit stream. The at least three bits extracted are used to traverse the lookup table. Subsequently, a data set corresponding to a Huffman code word is accessed, thereby decoding the input bit stream.Type: GrantFiled: March 5, 2009Date of Patent: August 10, 2010Assignee: Freescale Semiconductor, Inc.Inventors: Srinidhi Thirumalae Narayana, Shyam Krishnan Moni